Alpha 2.0
Login Register
» Authors » B Modder

B Modder

Explore the profile of B Modder including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 86
Followers 0
Related Specialties
General Medicine
Oncology
Pathology
Top 10 Co-Authors
R Fischer
G Ollenschlager
H E Schaefer
I Meuthen
J Thiele
G R Krueger
V Diehl
R Zankovich
J W Fisher
J Zach
Published In
Med Welt
Med Klin (Munich)
Dtsch Med Wochenschr
Rontgenblatter
Contrib Nephrol
Affiliations
Soon will be listed here.
Recent Articles
1.
[So-called primary (idiopathic) osteomyelofibrosis/-sclerosis (OMF) within the scope of chronic myeloproliferative diseases. II. Course and therapy in 102 patients with special reference to early hyperplastic and advanced fibrosclerotic stages]
Zankovich R, Thiele J, Modder B, Steinberg T, Simon K, Fischer R, et al.
Med Klin (Munich) . 1988 Oct; 83(19):629-36. PMID: 3185421
No abstract available.
2.
[So-called primary (idiopathic) osteomyelofibrosis/-sclerosis (OMF) within the scope of chronic myeloproliferative diseases. I. Initial clinical and histologic findings in 102 patients with special reference to early hyperplastic and advanced...]
Zankovich R, Thiele J, Modder B, Steinberg T, Simon K, Fischer R, et al.
Med Klin (Munich) . 1988 Oct; 83(19):617-28. PMID: 3185420
No abstract available.
3.
Asparaginase-induced derangements of glutamine metabolism: the pathogenetic basis for some drug-related side-effects
Ollenschlager G, Roth E, Linkesch W, Jansen S, SIMMEL A, Modder B
Eur J Clin Invest . 1988 Oct; 18(5):512-6. PMID: 3147904
Several side-effects of asparaginase therapy have been said to be a consequence of the glutaminase activity of Escherichia coli asparaginase, especially the deleterious influence on the liver function. We report...
4.
[Oral polychemotherapy in far advanced recurrences of Hodgkin's disease]
SCHAEFER H, Ollenschlager G, Modder B
Onkologie . 1988 Oct; 11(5):233-6. PMID: 3059250
In 10 patients with heavily pretreated Hodgkin's disease (stage IVA or IVB) a third-line salvage therapy consisting of CCNU, etoposide and chlorambucil (CECh) was tested. All patients were resistant to...
5.
Indications for and results of nutritional therapy in cancer patients
Ollenschlager G, Konkol K, Modder B
Recent Results Cancer Res . 1988 Jan; 108:172-84. PMID: 3140319
No abstract available.
6.
[Primary (essential) thrombocythemia. Clinical findings, course and therapy in 26 patients]
Modder B, Zankovich R, Thiele J, Kremer B, Fonatsch C, Fischer R, et al.
Med Klin (Munich) . 1987 Sep; 82(19):635-46. PMID: 3316962
No abstract available.
7.
[Metabolic complications in long-term parenteral nutrition. II]
Ollenschlager G, Fischer H, Modder B
Med Klin (Munich) . 1987 Sep; 82(19):666-9, 677. PMID: 3119971
No abstract available.
8.
[Metabolic complications in long-term parenteral nutrition. I]
Ollenschlager G, Fischer H, Modder B
Med Klin (Munich) . 1987 Sep; 82(18):619-23. PMID: 3119970
No abstract available.
9.
Cell membrane fluidity in chronic lymphocytic leukemia (CLL) lymphocytes and its relation to membrane receptor expression
Daefler S, Krueger G, Modder B, Deliconstantinos G
J Exp Pathol . 1987 Jan; 3(2):147-54. PMID: 2961855
Cell membrane fluidity (CMF), Ig receptor expression and ecto-ATPase activity were investigated in lymphocytes from patients with chronic lymphocytic leukemia (CLL) and from healthy controls. Significant differences were observed in...
10.
[Pseudohyperkalemia in the serum in reactive thrombocytosis and thrombocythemia]
Modder B, Meuthen I
Dtsch Med Wochenschr . 1986 Feb; 111(9):329-32. PMID: 3948731
In 80 patients with different platelet counts serum and plasma potassium concentration was measured, 30 minutes after blood sampling and three and six hours of storage. Serum and plasma concentrations...